Editas Medicine (EDIT)
Develops an in vivo CRISPR candidate for lowering LDL cholesterol.
$2.97
vs last close+0.05 (+1.71%)
Something off on this page? Send us feedback.
Next report
Nov 9, 26
in 47 days
EPS estimate
−$0.21
Revenue estimate
$4.5M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.55−$0.92−$0.63−$0.28−$0.06−$0.26−$0.15Pending
Estimate−$0.39−$0.56−$0.41−$0.38−$0.27−$0.30−$0.27−$0.21
Surprise−41.0%−63.1%−53.7%+26.3%+77.8%+13.3%+44.5%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$30.6M$4.7M$3.6M$7.5M$24.7M$2.8M$11.9MPending
Estimate$640.3K$641.9K$1.8M$8.5M$8.3M$6.4M$2.8M$4.5M
Surprise+4,680.0%+625.6%+97.0%−10.8%+196.3%−55.6%+317.7%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.14 | — | — |
| Sep 2027 | −$0.19 | — | — |
| Jun 2027 | −$0.18 | — | — |
| Mar 2027 | −$0.18 | — | — |
| Dec 2026 | −$0.18 | — | — |
| Nov 2026 | −$0.21 | — | — |
| Aug 2026 | −$0.27 | −$0.15 | +44.5% |
| May 2026 | −$0.30 | −$0.26 | +13.3% |
| Mar 2026 | −$0.27 | −$0.06 | +77.8% |
| Nov 2025 | −$0.38 | −$0.28 | +26.3% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Feb 2016 | |||
| Jun 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.14 | — | — | $14.1M | — | — | — |
| Sep 2027 | −$0.19 | — | — | $3.2M | — | — | — |
| Jun 2027 | −$0.18 | — | — | $3.2M | — | — | — |
| Mar 2027 | −$0.18 | — | — | $3.1M | — | — | — |
| Dec 2026 | −$0.18 | — | — | $6.7M | — | — | — |
| Nov 9, 2026 | −$0.21 | — | — | $4.5M | — | — | — |
| Aug 5, 2026 | −$0.27 | −$0.15 | +44.5% | $2.8M | $11.9M | +317.7% | +5.5% |
| May 5, 2026 | −$0.30 | −$0.26 | +13.3% | $6.4M | $2.8M | −55.6% | +1.3% |
| Mar 9, 2026 | −$0.27 | −$0.06 | +77.8% | $8.3M | $24.7M | +196.3% | +16.0% |
| Nov 10, 2025 | −$0.38 | −$0.28 | +26.3% | $8.5M | $7.5M | −10.8% | +2.0% |
| Aug 12, 2025 | |||||||
| May 12, 2025 | |||||||
| Mar 5, 2025 | |||||||
| Nov 4, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 8, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 3, 2023 | |||||||
| Aug 2, 2023 | |||||||
| May 5, 2023 | |||||||
| Feb 22, 2023 | |||||||
| Nov 2, 2022 | |||||||
| Aug 3, 2022 | |||||||
| May 4, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 8, 2021 | |||||||
| Aug 4, 2021 | |||||||
| May 5, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 6, 2020 | |||||||
| May 7, 2020 | |||||||
| Feb 26, 2020 | |||||||
| Nov 12, 2019 | |||||||
| Aug 6, 2019 | |||||||
| May 7, 2019 | |||||||
| Feb 28, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 6, 2018 | |||||||
| May 3, 2018 | |||||||
| Mar 6, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 9, 2017 | |||||||
| May 15, 2017 | |||||||
| Mar 7, 2017 | |||||||
| Nov 7, 2016 | |||||||
| Aug 9, 2016 | |||||||
| May 16, 2016 | |||||||
| Mar 30, 2016 | |||||||
| Feb 3, 2016 | |||||||
| Jun 30, 2015 |